Sign in
4

Changes in Ownership

CalciMedica, Inc. Filed Acc 0001209191-23-020679

Chief Scientific Officer acquired 11,944 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stauderman Kenneth A. Chief Scientific Officer 2023-03-20 Grant or award +11,944 11,944 D
Derivatives
Stauderman Kenneth A. Chief Scientific Officer 2023-03-20 Grant or award · Employee Stock Option (right to buy) +22,777 22,777 D
Stauderman Kenneth A. Chief Scientific Officer 2023-03-20 Grant or award · Employee Stock Option (right to buy) +8,640 8,640 D
Stauderman Kenneth A. Chief Scientific Officer 2023-03-20 Grant or award · Employee Stock Option (right to buy) +21,647 21,647 D
Stauderman Kenneth A. Chief Scientific Officer 2023-03-20 Grant or award · Employee Stock Option (right to buy) +7,264 7,264 D
Stauderman Kenneth A. Chief Scientific Officer 2023-03-20 Grant or award · Employee Stock Option (right to buy) +13,147 13,147 D
Stauderman Kenneth A. Chief Scientific Officer 2023-03-20 Grant or award · Employee Stock Option (right to buy) +7,264 7,264 D
Stauderman Kenneth A. Chief Scientific Officer 2023-03-20 Grant or award · Employee Stock Option (right to buy) +5,472 5,472 D
Stauderman Kenneth A. Chief Scientific Officer 2023-03-20 Grant or award · Employee Stock Option (right to buy) +661 661 D
Stauderman Kenneth A. Chief Scientific Officer 2023-03-20 Grant or award · Employee Stock Option (right to buy) +1,954 1,954 D
Stauderman Kenneth A. Chief Scientific Officer 2023-03-20 Grant or award · Employee Stock Option (right to buy) +2,090 2,090 D
Stauderman Kenneth A. Chief Scientific Officer 2023-03-20 Grant or award · Employee Stock Option (right to buy) +18,991 18,991 D
Stauderman Kenneth A. Chief Scientific Officer 2023-03-20 Grant or award · Employee Stock Option (right to buy) +1,877 1,877 D
Loading xslF345X04/doc4.xml…